Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics.

Seok KimJi-In BangDachung BooBorham KimIn Young ChoiSooJeong KoIe Ryung YooKwangsoo KimJunmo KimYoungHwan JooHyun Gee RyooJin Chul PaengJung Mi ParkWoncheol JangByungwon KimYangha ChungDongyoon YangSooyoung YooHo-Young Lee

Published in: European journal of nuclear medicine and molecular imaging (2022)

There was no significant difference of the SPM risk between TC patients treated with I-131 and propensity-matched TC patients without I-131 therapy.

Keyphrases

end stage renal disease
healthcare
newly diagnosed
ejection fraction
public health
chronic kidney disease
mental health
big data
prognostic factors
peritoneal dialysis
patient reported outcomes
mesenchymal stem cells
risk assessment
artificial intelligence
climate change
deep learning
health promotion